These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2582067)

  • 21. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
    Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
    J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
    Schiller JH; Storer B; Paulnock DM; Brown RR; Datta SP; Witt PL; Borden EC
    J Clin Invest; 1990 Oct; 86(4):1211-21. PubMed ID: 2120284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon and 2-5A synthetase in patients with immune diseases.
    Preble OT; Yeh TJ; Silverman RH; Klippel JH; Straus SE; Gelmann EP
    Prog Clin Biol Res; 1985; 202():415-22. PubMed ID: 2421319
    [No Abstract]   [Full Text] [Related]  

  • 24. Defective killer cell activity in patients with chronic active Epstein-Barr virus infection.
    Wakiguchi H; Fujieda M; Matsumoto K; Ohara Y; Wakiguchi A; Kurashige T
    Acta Med Okayama; 1988 Jun; 42(3):137-42. PubMed ID: 2840801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis.
    Weiss ER; Alter G; Ogembo JG; Henderson JL; Tabak B; Bakiş Y; Somasundaran M; Garber M; Selin L; Luzuriaga K
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27733645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD8 lymphocytes during Epstein Barr virus (EBV) infection: A CD29 positive population is expanded in acute infectious mononucleosis.
    de Paoli P; Gennari D; Reitano M; Martelli P; Sacilotto C; Comoretto R; Santini G
    Allergol Immunopathol (Madr); 1991; 19(2):95-7. PubMed ID: 1722959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2'-5' oligo(A) synthetase levels in interferon-sensitive or -resistant lymphoid cells.
    Koliais SI; Kortsaris A
    J Gen Virol; 1982 Jan; 58 Pt 1():191-3. PubMed ID: 6183394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level.
    Lipinski M; Fridman WH; Tursz T; Vincent C; Pious D; Fellous M
    J Exp Med; 1979 Dec; 150(6):1310-22. PubMed ID: 229186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyclonal proliferation of activated suppressor/cytotoxic T cells with transient depression of natural killer cell function in acute infectious mononucleosis.
    Williams ML; Loughran TP; Kidd PG; Starkebaum GA
    Clin Exp Immunol; 1989 Jul; 77(1):71-6. PubMed ID: 2527653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory.
    Steven NM; Leese AM; Annels NE; Lee SP; Rickinson AB
    J Exp Med; 1996 Nov; 184(5):1801-13. PubMed ID: 8920868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
    Jondal M
    Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.
    Svedmyr E; Jondal M
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1622-6. PubMed ID: 165518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
    Hudnall SD; Patel J; Schwab H; Martinez J
    Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferon.
    Thorley-Lawson DA
    J Immunol; 1981 Mar; 126(3):829-33. PubMed ID: 6161964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-beta serine.
    Goldstein D; Sielaff KM; Storer BE; Brown RR; Datta SP; Witt PL; Teitelbaum AP; Smalley RV; Borden EC
    J Natl Cancer Inst; 1989 Jul; 81(14):1061-8. PubMed ID: 2472488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deficient natural killer cell activity in x-linked lymphoproliferative syndrome.
    Sullivan JL; Byron KS; Brewster FE; Purtilo DT
    Science; 1980 Oct; 210(4469):543-5. PubMed ID: 6158759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Life-threatening infectious mononucleosis: is it correlated with virus-induced T cell proliferation?
    Baumgarten E; Herbst H; Schmitt M; Seeger KH; Schulte-Overberg U; Henze G
    Clin Infect Dis; 1994 Jul; 19(1):152-6. PubMed ID: 7948520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon production potentials of various human lymphoblastoid cell lines.
    Matsuyama M; Sairenji T; Yonemura K; Hinuma Y
    Microbiol Immunol; 1982; 26(12):1149-58. PubMed ID: 6188944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.